Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Paoletti · SciRah

Researcher profile · Semantic Scholar

C. Paoletti

Share profile

C. Paoletti — researcher profile on SciRah

h-index: 22
Works: 61
Citations: 2,431

Most-cited papers

Sensitive capture of circulating tumour cells by functionalised graphene oxide nanosheets
H. Yoon, Tae Hyun Kim, Zhuo-jun Zhang, E. Azizi +8 more
2013Nature Nanotechnology502 citations Open access
Semantic Scholar
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
F. Bidard, T. Fehm, M. Ignatiadis, J. Smerage +8 more
2012Cancer Metastasis Review247 citations Open access
Semantic Scholar
Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes.
Q. Kang, N. L. Henry, C. Paoletti, Hui Jiang +6 more
2016Clinical Biochemistry207 citations
Semantic Scholar
ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patients
D. Chu, C. Paoletti, C. Gersch, Dustin A. VanDenBerg +25 more
2015Clinical Cancer Research172 citations Open access
Semantic Scholar
Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor Positive Breast Cancer
C. Paoletti, Maria C. Muñiz, Dafydd Thomas, K. Griffith +12 more
2014Clinical Cancer Research127 citations Open access
Semantic Scholar
A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells
Tae Hyun Kim, Yang Wang, C. Oliver, D. Thamm +5 more
2019Nature Communications112 citations Open access
Semantic Scholar
Monitoring apoptosis and Bcl‐2 on circulating tumor cells in patients with metastatic breast cancer
Jeffrey B. Smerage, G. Budd, G. Doyle, Marty Brown +8 more
2013Molecular Oncology102 citations Open access
Semantic Scholar
Comprehensive mutation and copy number profiling in archived circulating breast cancer tumor cells documents heterogeneous resistance mechanisms
C. Paoletti, A. Cani, José M. Larios, D. Hovelson +23 more
2017Cancer Research94 citations Open access
Semantic Scholar
Temperature and pH sensors based on graphenic materials.
P. Salvo, N. Calisi, B. Melai, B. Cortigiani +11 more
2017Biosensors & bioelectronics94 citations Open access
Semantic Scholar
Molecular testing in breast cancer.
C. Paoletti, D. Hayes
2014Annual Review of Medicine82 citations Open access
Semantic Scholar
Significance of Circulating Tumor Cells in metastatic triple negative breast cancer patients within a randomized, phase II trial: TBCRC 019
C. Paoletti, Yu-Feng Li, Maria C. Muñiz, K. Kidwell +16 more
2015Clinical Cancer Research81 citations Open access
Semantic Scholar
Circulating Tumor Cell Clusters in patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study
C. Paoletti, Jie-Ling Miao, E. Dolce, E. Darga +7 more
2019Clinical Cancer Research57 citations Open access
Semantic Scholar
Circulating tumour cells: insights into tumour heterogeneity
D. Hayes, C. Paoletti
2013Journal of Internal Medicine55 citations Open access
Semantic Scholar
Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial
C. Paoletti, G. Schiavon, E. Dolce, Elizabeth P. Darga +23 more
2018Clinical Cancer Research53 citations Open access
Semantic Scholar
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer
E. Darga, E. Dolce, Fang Fang, K. Kidwell +12 more
2021PLoS ONE48 citations Open access
Semantic Scholar
Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression
P. Pinzani, C. Mazzini, F. Salvianti, D. Massi +7 more
2010Melanoma research46 citations
Semantic Scholar
Circulating tumor cells
F. Bidard, S. Ligthart, T. Bachelot, S. Delaloge +49 more
201242 citations Open access
Semantic Scholar
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
T. Aparicio, M. Ducreux, R. Faroux, E. Barbier +305 more
2018European Journal of Cancer41 citations Open access
Semantic Scholar
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
C. Paoletti, José M. Larios, Maria C. Muñiz, K. Aung +12 more
2016Molecular Oncology41 citations Open access
Semantic Scholar
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
C. Paoletti, M. Regan, S. Niman, E. Dolce +15 more
2021npj Breast Cancer23 citations Open access
Semantic Scholar
Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichment.
K. Smith, J. Jana, Anna Kaehr, Emma Purcell +6 more
2021Lab on a Chip22 citations
Semantic Scholar
Characterizing Circulating Tumor Cells Isolated from Metastatic Breast Cancer Patients Using Graphene Oxide Based Microfluidic Assay
Tae Hyun Kim, H. Yoon, S. Fouladdel, Yang Wang +7 more
2018Advanced Biosystems22 citations
Semantic Scholar
Erratum: Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets (Nature Nanotechnology (2013) 8 (735-741))
H. Yoon, Tae Hyun Kim, Zhuo Zhang, E. Azizi +8 more
201319 citations Open access
Semantic Scholar
Evaluating Serum Thymidine Kinase 1 in Hormone Receptor Positive Metastatic Breast Cancer Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial
C. Paoletti, W. Barlow, E. Cobain, M. Bergqvist +10 more
2021Clinical Cancer Research18 citations Open access
Semantic Scholar
Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection
A. Cani, E. Dolce, E. Darga, Kevin Hu +28 more
2021Molecular Oncology18 citations Open access
Semantic Scholar
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer
A. Nanou, Jieling Miao, F. Coumans, E. Dolce +11 more
2023JCO Precision Oncology16 citations Open access
Semantic Scholar
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
B. Neri, P. Pantaleo, E. Giommoni, R. Grifoni +6 more
2007British Journal of Cancer14 citations Open access
Semantic Scholar
BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received: Dawson S-J, Makretsov N, Blows FM, et al (Univ of Cambridge, UK; et al) Br J Cancer 103:668-675, 2010
D. Hayes, C. Paoletti
201113 citations
Semantic Scholar
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)
M. Bergqvist, Adrian Nordmark, Amy Williams, C. Paoletti +12 more
2023Biomarkers10 citations Open access
Semantic Scholar
Diagnosis of Oral Cancer With Deep Learning. A Comparative Test Accuracy Systematic Review
M. Nieri, L. Serni, Tommaso Clauser, C. Paoletti +1 more
2025Oral Diseases9 citations Open access
Semantic Scholar
Clinical Applications of Circulating Tumor Cells in Breast Cancer.
E. Cobain, C. Paoletti, J. Smerage, D. Hayes
2019Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer9 citations
Semantic Scholar
Long-Term Survival in Metastatic Melanoma Patients Treated with Sequential Biochemotherapy: Report of a Phase II Study
B. Neri, L. Vannozzi, C. Fulignati, P. Pantaleo +5 more
2006Cancer Investigation9 citations Open access
Semantic Scholar
Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial
C. Paoletti, M. Regan, M.-C. Liu, P. Marcom +15 more
20177 citations
Semantic Scholar
Abstract OT1-3-01: Characterization of circulating tumor cells from subjects with metastatic breast cancer using the CTC-endocrine therapy index: The COMETI-P2-2012.0 trial
C. Paoletti
20136 citations
Semantic Scholar
Circulating Tumor Cells.
C. Paoletti, Daniel F. Hayes
2016Advances in Experimental Medicine and Biology5 citations
Semantic Scholar
Abstract CT523: An open-label, multicenter, phase 1b/2 Study of E7386 (Wnt/β-catenin pathway inhibitor) + pembrolizumab in patients with pretreated advanced solid tumors
T. Yoshino, M. Ikeda, R. Finn, T. R. Jeffry Evans +6 more
2022Cancer Research4 citations
Semantic Scholar
Abstract 4154: Multi-parameter molecular characterization of circulating tumor cells (CTC): Development of a CTC-endocrine therapy index (CTC-ETI)
C. Paoletti, Martha E. Brown, Maria C. Muñiz, J. Rae +2 more
20112 citations
Semantic Scholar
P4-07-16: Development of Circulating Tumor Cell-Endocrine Therapy Index in Metastatic Breast Cancer Patients.
C. Paoletti, M. Connelly, D. Chianese, Martha E. Brown +4 more
20112 citations
Semantic Scholar
A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms
T. R. Jeffry Evans, N. Cook, A. El-Khoueiry, D. Pinato +10 more
2026British Journal of Cancer1 citations Open access
Semantic Scholar
Abstract 5595: Serial monitoring of circulating tumor cells and circulating tumor DNA in metastatic lobular breast cancer identifies intra-tumor heterogeneity and precision and immuno-oncology biomarkers of therapeutic importance
A. Cani, E. Dolce, Kevin Hu, C. Liu +11 more
2023Cancer Research1 citations
Semantic Scholar
Abstract 1700: Serial monitoring of single-cell circulating tumor cell genomics in metastatic lobular breast cancer to identify precision and immuno-oncology biomarkers with therapeutic implications
A. Cani, E. Dolce, E. Darga, Kevin Hu +9 more
2022Cancer Research1 citations
Semantic Scholar
Abstract PS2-04: Evaluating serum thymidine kinase 1 in hormone receptor positive metastatic breast cancer patients receiving first line endocrine therapy in the SWOG S0226 trial
C. Paoletti, W. Barlow, M. Bergqvist, R. Mehta +9 more
2021Poster Session Abstracts1 citations
Semantic Scholar
Leveraging E7386 phase 1 trials for cardiac safety: Gaining concentration-QTc insights to inform early-stage oncology development.
Shriram M. Pathak, N. Hayata, J. Lopez, Natalie Cook +12 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Circulating tumor cells in patients with hormone receptor-positive, HER2-negative metastatic breast cancer receiving palbociclib with fulvestrant after progression on palbociclib with an aromatase inhibitor.
Jessica Tao, Ruizhe Chen, A. Blackford, T. Cescon +14 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.
E. Cobain, W. Barlow, C. Paoletti, M. Bergqvist +12 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract P4-02-04: Serial monitoring of circulating tumor cells and circulating tumor DNA in metastatic lobular breast cancer identifies intra-tumor heterogeneity and precision and immuno-oncology biomarkers of therapeutic importance
A. Cani, E. Dolce, Alissa Turnbull, Kevin Hu +12 more
2023Cancer Research0 citations
Semantic Scholar
Abstract 611: Assessment of tumor mutation burden and microsatellite instability by single-cell circulating tumor cell genomic profiling
A. Cani, E. Dolce, C. Liu, B. Rupp +12 more
2022Cancer Research0 citations
Semantic Scholar
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
C. Paoletti, M. Regan, S. Niman, E. Dolce +15 more
2021npj Breast Cancer0 citations Open access
Semantic Scholar
Abstract 3143: Monitoring circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) genomic alterations in ER positive (POS)/HER2 negative (NEG) advanced breast cancer during endocrine therapy: correlative study of AZD9496 oral SERD phase I trial
A. Cani, E. Dolce, E. Darga, Kevin Hu +25 more
2021Tumor Biology0 citations
Semantic Scholar
Author response for "Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection"
A. Cani, E. Dolce, Elizabeth P. Darga, Kevin Hu +28 more
20210 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Hayes×23
Invite
D. Hayes — researcher profile on SciRah
E. Darga×14
Invite
E. Darga — researcher profile on SciRah
J. Rae×13
Invite
J. Rae — researcher profile on SciRah
E. Dolce×13
Invite
E. Dolce — researcher profile on SciRah

×12

Invite

K. Aung — researcher profile on SciRah

Martha E. Brown×11

Invite

Martha E. Brown — researcher profile on SciRah

Invite

E. Cobain — researcher profile on SciRah

Dafydd Thomas×8

Invite

Dafydd Thomas — researcher profile on SciRah

Invite

A. Cani — researcher profile on SciRah

Invite

C. Liu — researcher profile on SciRah

A. Chinnaiyan×7

Invite

A. Chinnaiyan — researcher profile on SciRah

Maria C. Muñiz×7

Invite

Maria C. Muñiz — researcher profile on SciRah